1-2 of 2
Helene Labussiere, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants From 10/10 HLA Unrelated Donors and Siblings

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Marie Y. Detrait, MD, Helene Labussiere, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Jihane Fattoum, MD, PhD, Youcef Chelghoum, MD, Xavier Thomas, MD, PhD, Franck E. Nicolini, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3087.
https://doi.org/10.1182/blood.V118.21.3087.3087
Published: 2011
Journal Articles

The Month Three Major Molecular Response in Chronic Phase Chronic Myeloid Leukemia on imatinib 400 , Nilotinib and Dasatinib Is a Major Prognostic Factor for Failure-Free and Progression-Free Survival

Franck E Nicolini, MD, PhD, Sandrine Hayette, PhD, Helene Labussiere, MD, PhD, Madeleine Etienne, CRA, Marie-Pierre Fort, Elodie Gadolet, CRA, Isabelle Tigaud, MD, Kaddour Chabane, Eric Lippert, MD, Mohamad Sobh, Pharm.M., Stephanie Dulucq, MD, Stephane Morisset, Stat., Mauricette Michallet, Francois-Xavier Mahon, MD, PhD, Gabriel Etienne, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1684.
https://doi.org/10.1182/blood.V118.21.1684.1684
Published: 2011